By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Tekmira Pharmaceuticals Corporation 

100-8900 Glenlyon Parkway

Burnaby  British Columbia  V5J 5J8  Canada
Phone: 604-419-3200 Fax: 604-419-3201



Company News
Ebola Clinical Trials: Big Name Players In The Ebola Race 10/20/2014 3:28:01 AM
Tekmira (TKMR) Presents Results Of Preclinical Studies With Hepatitis B Therapeutic 10/16/2014 7:15:56 AM
Tekmira (TKMR)'s Partner Reports Positive Clinical Data For LNP-Enabled Patisiran 10/14/2014 5:43:13 AM
FDA Modifies Tekmira (TKMR)'s TKM-Ebola Clinical Hold To Partial Hold 10/10/2014 3:00:23 PM
Tekmira (TKMR) To Present HBV Pre-Clinical Data At Meeting Of The Oligonucleotide Therapeutics Society 10/10/2014 7:12:07 AM
Tekmira (TKMR) Working Hand In Hand With WHO On Ebola Drug, Says CEO 10/8/2014 2:27:34 AM
Traders’ Infatuation With Ebola Drugs Causing “Rollercoaster” Market, Says Tekmira (TKMR) CEO 10/8/2014 2:03:45 AM
Tekmira Pharmaceuticals Corporation (TKMR) To Present At Biotechnology Industry Organization (BIO) Investor Forum 10/3/2014 7:09:27 AM
Tekmira Pharmaceuticals Corporation (TKMR) Achieves $1.5 Million Development Milestone 10/3/2014 7:06:22 AM
Tekmira Pharmaceuticals Corporation (TKMR) Joins International Consortium To Conduct Clinical Trials Of Ebola Virus Therapeutics In West Africa 9/23/2014 8:12:26 AM